| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 4.78% | Cantor Fitzgerald | → $374 | Reiterates | Overweight → Overweight |
| 11/17/2023 | 9.83% | JP Morgan | $367 → $392 | Maintains | Overweight |
| 10/03/2023 | -1.94% | Stephens & Co. | → $350 | Reiterates | Equal-Weight → Equal-Weight |
| 09/14/2023 | 0.58% | Cantor Fitzgerald | → $359 | Reiterates | Overweight → Overweight |
| 07/14/2023 | 2.26% | Morgan Stanley | $365 → $365 | Reiterates | Overweight → Overweight |
| 07/07/2023 | -4.46% | JP Morgan | $348 → $341 | Maintains | Overweight |
| 06/20/2023 | 2.26% | Truist Securities | $380 → $365 | Maintains | Buy |
| 06/20/2023 | -13.15% | UBS | → $310 | Initiates Coverage On | → Neutral |
| 05/08/2023 | -6.14% | Deutsche Bank | $365 → $335 | Maintains | Hold |
| 05/03/2023 | -2.22% | TD Cowen | $380 → $349 | Maintains | Outperform |
| 05/01/2023 | 2.26% | Deutsche Bank | $356 → $365 | Maintains | Hold |
| 04/28/2023 | -1.94% | Credit Suisse | $347 → $350 | Maintains | Outperform |
| 04/28/2023 | -18.75% | Wells Fargo | $282 → $290 | Maintains | Underweight |
| 04/27/2023 | -1.94% | Stephens & Co. | → $350 | Reiterates | → Equal-Weight |
| 04/21/2023 | -0.82% | Cantor Fitzgerald | → $354 | Initiates Coverage On | → Overweight |
| 03/21/2023 | -20.99% | Wells Fargo | $307 → $282 | Maintains | Underweight |
| 02/23/2023 | -2.5% | JP Morgan | $360 → $348 | Maintains | Overweight |
| 02/17/2023 | -13.99% | Wells Fargo | $340 → $307 | Maintains | Underweight |
| 02/10/2023 | 6.46% | Truist Securities | $400 → $380 | Maintains | Buy |
| 02/10/2023 | -2.78% | Credit Suisse | $395 → $347 | Maintains | Outperform |
| 02/09/2023 | 5.06% | Stephens & Co. | → $375 | Maintains | Equal-Weight |
| 01/04/2023 | 5.06% | Barclays | $400 → $375 | Maintains | Overweight |
| 01/03/2023 | -4.74% | Wells Fargo | $345 → $340 | Maintains | Underweight |
| 12/13/2022 | 8.7% | B of A Securities | → $388 | Upgrades | Underperform → Neutral |
| 11/01/2022 | -0.54% | Deutsche Bank | $315 → $355 | Maintains | Hold |
| 10/28/2022 | 12.07% | Barclays | $380 → $400 | Maintains | Overweight |
| 10/28/2022 | 17.67% | Truist Securities | $390 → $420 | Maintains | Buy |
| 10/27/2022 | 14.87% | Credit Suisse | $350 → $410 | Maintains | Outperform |
| 10/03/2022 | 0.86% | JP Morgan | → $360 | Initiates Coverage On | → Overweight |
| 08/26/2022 | -3.34% | Wells Fargo | $307 → $345 | Maintains | Underweight |
| 07/29/2022 | 2.54% | Mizuho | $345 → $366 | Maintains | Buy |
| 07/29/2022 | 6.46% | Barclays | $340 → $380 | Maintains | Overweight |
| 06/17/2022 | -13.15% | Loop Capital | → $310 | Initiates Coverage On | → Hold |
| 05/26/2022 | -6.14% | B of A Securities | $355 → $335 | Downgrades | Buy → Underperform |
| 05/25/2022 | -15.67% | Wells Fargo | $308 → $301 | Maintains | Underweight |
| 05/02/2022 | -12.87% | Deutsche Bank | $308 → $311 | Maintains | Hold |
| 02/22/2022 | 2.26% | Morgan Stanley | $397 → $365 | Maintains | Overweight |
| 02/14/2022 | 6.46% | BMO Capital | $365 → $380 | Maintains | Outperform |
| 02/11/2022 | -3.34% | Mizuho | $330 → $345 | Maintains | Buy |
| 12/14/2021 | -6.14% | Goldman Sachs | → $335 | Initiates Coverage On | → Buy |
| 11/02/2021 | -21.27% | Wells Fargo | $256 → $281 | Maintains | Underweight |
| 10/29/2021 | 11.23% | Morgan Stanley | $316 → $397 | Maintains | Overweight |
| 10/29/2021 | -15.95% | Stephens & Co. | $280 → $300 | Maintains | Equal-Weight |
| 10/29/2021 | -7.54% | Credit Suisse | $318 → $330 | Maintains | Outperform |
| 10/29/2021 | -4.74% | Barclays | $310 → $340 | Maintains | Overweight |
| 09/20/2021 | -10.91% | Credit Suisse | $280 → $318 | Maintains | Outperform |
| 09/20/2021 | -7.54% | Truist Securities | $300 → $330 | Maintains | Buy |
| 09/20/2021 | -21.55% | Stephens & Co. | $260 → $280 | Maintains | Equal-Weight |
| 09/20/2021 | -11.47% | Morgan Stanley | $296 → $316 | Maintains | Overweight |
| 09/20/2021 | -14.55% | Mizuho | $284 → $305 | Maintains | Buy |
| 08/31/2021 | -17.07% | Morgan Stanley | $297 → $296 | Maintains | Overweight |
| 08/03/2021 | -28.28% | Wells Fargo | $253 → $256 | Maintains | Underweight |
| 07/30/2021 | -11.75% | BMO Capital | $300 → $315 | Maintains | Outperform |
| 07/30/2021 | -20.43% | Mizuho | $273 → $284 | Maintains | Buy |
| 06/03/2021 | -16.79% | Morgan Stanley | $244 → $297 | Maintains | Overweight |
| 05/19/2021 | -29.12% | Wells Fargo | → $253 | Initiates Coverage On | → Underweight |
| 04/30/2021 | -23.51% | Mizuho | $245 → $273 | Maintains | Buy |
| 04/14/2021 | -18.75% | Truist Securities | $260 → $290 | Maintains | Buy |
| 03/30/2021 | -27.16% | Credit Suisse | → $260 | Initiates Coverage On | → Outperform |
| 03/10/2021 | -31.36% | Mizuho | → $245 | Initiates Coverage On | → Buy |
| 02/19/2021 | -27.16% | Barclays | → $260 | Reinstates | → Overweight |
| 10/30/2020 | -28.56% | SVB Leerink | $228 → $255 | Maintains | Outperform |
| 09/01/2020 | -36.12% | SVB Leerink | $226 → $228 | Maintains | Outperform |
| 08/03/2020 | -45.65% | Deutsche Bank | $188 → $194 | Maintains | Buy |
| 08/03/2020 | -36.68% | SVB Leerink | $220 → $226 | Maintains | Outperform |
| 07/01/2020 | -38.36% | SVB Leerink | → $220 | Initiates Coverage On | → Outperform |
| 06/16/2020 | -41.16% | Cowen & Co. | → $210 | Upgrades | Market Perform → Outperform |
| 05/15/2020 | -35.84% | Morgan Stanley | $175 → $229 | Maintains | Overweight |
| 05/04/2020 | -46.49% | CFRA | $141 → $191 | Upgrades | Hold → Buy |
| 05/04/2020 | -41.16% | SunTrust Robinson Humphrey | $185 → $210 | Maintains | Buy |
| 05/04/2020 | -41.73% | Piper Sandler | $194 → $208 | Maintains | Overweight |
| 05/04/2020 | -47.33% | Deutsche Bank | $206 → $188 | Maintains | Buy |
| 04/14/2020 | -47.33% | Stephens & Co. | $145 → $188 | Upgrades | Equal-Weight → Overweight |
| 04/13/2020 | -50.97% | Morgan Stanley | $165 → $175 | Maintains | Overweight |
| 04/13/2020 | -48.17% | SunTrust Robinson Humphrey | $165 → $185 | Maintains | Buy |
| 04/08/2020 | — | B of A Securities | Upgrades | Underperform → Buy | |
| 03/27/2020 | -53.77% | Morgan Stanley | $153 → $165 | Maintains | Overweight |
| 02/18/2020 | -42.29% | Deutsche Bank | $156 → $206 | Maintains | Buy |
| 02/12/2020 | -52.37% | BMO Capital | $152 → $170 | Maintains | Outperform |
| 02/11/2020 | -60.5% | CFRA | $128 → $141 | Maintains | Hold |
| 12/20/2019 | -57.41% | JP Morgan | $150 → $152 | Maintains | Overweight |
| 11/18/2019 | -53.77% | SunTrust Robinson Humphrey | $155 → $165 | Maintains | Buy |
| 11/07/2019 | -57.97% | JP Morgan | $173 → $150 | Maintains | Overweight |
| 10/31/2019 | -55.73% | Morgan Stanley | $172 → $158 | Maintains | Overweight |
| 10/30/2019 | -66.38% | Jefferies | $133 → $120 | Downgrades | Buy → Hold |
| 09/12/2019 | -59.38% | Deutsche Bank | → $145 | Initiates Coverage On | → Buy |
| 08/23/2019 | -51.81% | Morgan Stanley | $184 → $172 | Maintains | Overweight |
| 07/12/2019 | -48.45% | Morgan Stanley | $178 → $184 | Maintains | Overweight |
| 06/03/2019 | -43.97% | BMO Capital | $154 → $200 | Upgrades | Market Perform → Outperform |
| 05/31/2019 | -50.41% | Wells Fargo | → $177 | Upgrades | Market Perform → Outperform |
| 04/17/2019 | -63.58% | Barclays | $140 → $130 | Maintains | Equal-Weight |
| 02/28/2019 | — | Cowen & Co. | Initiates Coverage On | → Market Perform | |
| 02/13/2019 | -46.21% | Morgan Stanley | $180 → $192 | Maintains | Overweight |
| 01/14/2019 | -59.66% | Stephens & Co. | → $144 | Initiates Coverage On | → Equal-Weight |
| 01/08/2019 | -57.97% | JP Morgan | $127 → $150 | Upgrades | Neutral → Overweight |
What is the target price for Molina Healthcare (MOH)?
The latest price target for Molina Healthcare (NYSE: MOH) was reported by Cantor Fitzgerald on November 21, 2023. The analyst firm set a price target for $374.00 expecting MOH to rise to within 12 months (a possible 4.78% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Molina Healthcare (MOH)?
The latest analyst rating for Molina Healthcare (NYSE: MOH) was provided by Cantor Fitzgerald, and Molina Healthcare reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Molina Healthcare (MOH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molina Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molina Healthcare was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Molina Healthcare (MOH) correct?
While ratings are subjective and will change, the latest Molina Healthcare (MOH) rating was a reiterated with a price target of $0.00 to $374.00. The current price Molina Healthcare (MOH) is trading at is $356.93, which is within the analyst's predicted range.